Usage of Patient Specific Midbrain Organoids for In Vitro Modeling of Parkinson’s Disease
Tuesday, October 20, 2020 10am to 11:30am
About this Event
In the midbrain of patients with Parkinson’s disease (PD), the dopaminergic neurons of the substantia nigra region are vulnerable for degeneration, while those of the ventral tegmental area are not. This selective vulnerability is not understood, due to a lack of human-specific midbrain models. Schwamborn’s work shows that 3D differentiation of human midbrain neural progenitor cells leads to organoids that can produce and secrete dopamine, and contain other neuronal subtypes, astrocytes and oligodendrocytes. Enriching them with induced pluripotent stem cell derived microglia also generates patient and disease-specific midbrain organoids. Key hallmarks of PD can be recapitulated, while reproducibly generating 3D human midbrain organoids containing mDANs to investigate PD-relevant patho-mechanisms.
Jens Christian Schwamborn, PhD
Professor, Cellular and Developmental Biology
Luxembourg Centre for Systems Biomedicine (LCSB)
University of Luxembourg
Hosted by the Center for Neuroregeneration, Department of Neurosurgery
Event Details
Dial-In Information
Join Zoom Meeting
Meeting ID: 963 4113 3137
One tap mobile
+13462487799,,96341133137# US (Houston)
+16699006833,,96341133137# US (San Jose)
Dial by your location
+1 346 248 7799 US (Houston)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 312 626 6799 US (Chicago)
+1 929 436 2866 US (New York)
+1 301 715 8592 US (Germantown)
Meeting ID: 963 4113 3137
Find your local number: https://zoom.us/u/aKxvYpFr6